drugset / Trial / NCT00034905

A Comparison of Seroquel vs. Risperidone in Schizophrenia

NCT00034905

Phase 4 Completed AstraZeneca
Treatment

Summary

The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.

Timeline

Start
2001-07
Primary completion
2002-09
Completion
2002-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule
Subject Risperidone Other / unclassified

Indications